Cannasouth Board and Senior Management Team
Tony Ho – Independent Non-Executive Chairman
Tony has a Bachelor of Commerce degree from The University of New South Wales, Sydney, is a Member of The Institute of Chartered Accountants in Australia and New Zealand, a Fellow of The Institute of Chartered Secretaries and Administrators, a Fellow of the Australian Institute of Company Directors, and a Fellow of the Governance Institute of Australia.Tony holds numerous non-executive directorships with a number of ASX and NZX listed companies. He was previously a director of Yates New Zealand Limited.
Conor English – Independent Non-Executive Director
Conor has a broad agriculture background. He is Chairman of Agribusiness New Zealand Limited and NZX listed QEX Logistics Limited. He is a Director of GMP Pharmaceuticals Group Ltd, Esports New Zealand, and Quotable Value. He recently completed a 3 year term as one of only two external independent advisors to the Reserve Bank of New Zealand on monetary policy. He has had a number of other roles including 6 years as CEO of Federated Farmers. Conor has extensive good governance and business experience, with strong global insights around New Zealand products and exports, combined with strong international networks and relationships.
Mark Lucas – Executive Director and Chief Executive Officer
Mark is an experienced business manager who designs and implements operational business systems throughout Cannasouth. With strong data system DNA, Mark is a skilled manager who brings a wealth of business knowledge and experience to this role. Mark’s business background spans 25 years, an entrepreneur by nature with a passion for business Mark has been involved in a number of businesses from initial conception through to mature, well-established companies. Mark’s abilities encompass, management, human resources – staff, project management, contract negotiation, sales & marketing, financial control and business strategy.
Nic Foreman – Executive Director and Chief Operating Officer
Nic facilitates the implementation of the company’s agricultural and technical capacities. He also identifies opportunities for clinical research partnerships that will provide a better understanding of the therapeutic benefits of precise cannabinoid isolates for specific diseases. Nic’s business background has been focused on developing successful businesses in a number of sectors. Nic’s skill sets encompass, team inception, finance, management, marketing, technical expertise, research & development, legislative relationships, regulatory compliance, strategy and vision.
Rob Braithwaite – Chief Financial Officer
Rob is a chartered accountant with over 35 years’ experience within business advisory, corporate tax, planning and finance activities. As an Ex KPMG partner, Rob has a broad range of experience within this field both locally and internationally; he brings a rigorous commercial approach to tax planning and compliance.
Brenda van Zyl – Business Development Manager
Brenda’s recent business experience encompassed spending seven years in the USA leading a biotechnology manufacturing company from start-up, to fast growth, and right through to acquisition. Brenda has a Bachelor of Science and a Post-Graduate Diploma in Business and Administration and is an associate member of the New Zealand Institute of Directors. Her strengths are in the areas of innovation, vision, commercial management, progressive high-performance leadership and organisational culture management.
Cannasouth Plant Research – Advisory Group
Emeritus Professor Alistair Wilkins – Research & Scientific Advisor
BSc (Hons), PhD (Otago) Emeritus Professor, Chemistry Department, Waikato University, Hamilton. Alistair is an expert within the field of GCMS molecular structure elucidation, and associated sciences. He has advised and consulted widely both internationally and locally and is an expert in natural product organic chemistry.
Daniel Reason – Research & Scientific Advisor
Daniel holds a Bachelor of Science (Hons) at the University of Waikato majoring in Chemistry. He is now completing a PhD Doctoral Degree in chemistry focusing on cannabinoid research. With experience in analytical chemistry obtained through work at the British Geological Survey, Daniel is experienced in a range of scientific methodologies. He has recently returned from Europe, where he has been undergoing training and gaining experience regarding cannabinoid (CBD) research.
Zach Sufrin – Business Development Advisor
Zach currently serves as Manager, Business Development for Canopy Growth Corporation, a leading international cannabis company headquartered in Ontario, Canada. Prior to Canopy, Zach was Director of Business Development at ebbu Inc., a cannabis research company located in Colorado, U.S.A. In this role, Zach was responsible for licensing the company’s technology to third-parties. Prior to ebbu, Zach founded Homnibus LLC and was a Principal at Atlas Holdings LLC. Zach brings 15 years of experience in business strategy and deal structuring. Zach holds a B.A. in philosophy and neuroscience from Washington University in St. Louis. Zach is based in New York City.
Associate Professor Brett Langley – Research & Scientific Advisor
Brett Langley completed his PhD in Molecular Medicine from the University of Auckland. After postdoctoral work at Harvard Medical School, he joined the Faculty of Neurology and Neuroscience at Weill Medical College of Cornell University in New York, eventually becoming an Associate Professor. Brett is now an Associate Professor at the University of Waikato, where he continues his research into the molecular events that determine the brains function or fate following injury or during disease, and ultimately, whether they can be modulated therapeutically to promote better outcomes in patients.